Literature DB >> 21533876

Optimal phenotypic testing of AmpC beta-lactamases using boronic acid solutions.

W-Y Su1, T Gottlieb, J Merlino.   

Abstract

Plasmid-mediated class C β-lactamases are reported from Escherichia coli and Klebsiella pneumoniae with increasing frequency. No screening and confirmatory tests have been uniformly established for these strains. We investigated for the presence of plasmid-mediated AmpC production in 51 clinical isolates of Enterobacteriaceae, comparing two different boronic acid formulations, phenylboronic acid (PB) and 3-(N-Boc-amino)phenylboronic acid (APB), using polymerase chain reaction (PCR). PB performed better than APB.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21533876     DOI： 10.1007/s10096-011-1271-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  8 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Disc methods for detecting AmpC {beta}-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae.

Authors:  Nigel P Brenwald; Gail Jevons; Jenny Andrews; Lei Ang; Adam P Fraise
Journal:  J Antimicrob Chemother       Date:  2005-08-08       Impact factor: 5.790

3.  Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.

Authors:  T Y Tan; S Y Ng; L Teo; Y Koh; C H Teok
Journal:  J Clin Pathol       Date:  2007-12-05       Impact factor: 3.411

4.  Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis.

Authors:  Philip E Coudron
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.

Authors:  Tetsuya Yagi; Jun-ichi Wachino; Hiroshi Kurokawa; Satowa Suzuki; Kunikazu Yamane; Yohei Doi; Naohiro Shibata; Haru Kato; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

6.  Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae.

Authors:  Hyunjoo Pai; Cheol-In Kang; Jeong-Hum Byeon; Ki-Deok Lee; Wan Beom Park; Hong-Bin Kim; Eui-Chong Kim; Myoung-Don Oh; Kang-Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species.

Authors:  Peggy C Kohner; Frans J L Robberts; Franklin R Cockerill; Robin Patel
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

8.  Identification of plasmid-mediated AmpC beta-lactamases in Escherichia coli, Klebsiella spp., and proteus species can potentially improve reporting of cephalosporin susceptibility testing results.

Authors:  Fred C Tenover; Shannon L Emery; Carol A Spiegel; Patricia A Bradford; Samantha Eells; Andrea Endimiani; Robert A Bonomo; John E McGowan
Journal:  J Clin Microbiol       Date:  2008-11-26       Impact factor: 5.948
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.